Broadfin Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-410,532	Closed	-$8.04M	–	63
2018 Q3	$8.04M	Sell	410,532 -929,043	-69%	-$17.7M	1.44%	26
2018 Q2	$22.2M	Sell	1,339,575 -1,224,600	-48%	-$18.7M	3.73%	9
2018 Q1	$36.4M	Sell	2,564,175 -453,846	-15%	-$6.7M	5.75%	4
2017 Q4	$44.1M	Sell	3,018,021 -79,943	-3%	-$1.12M	7.27%	2
2017 Q3	$39.3M	Sell	3,097,964 -962,883	-24%	-$12.2M	6.09%	4
2017 Q2	$48.2M	Sell	4,060,847 -1,603,372	-28%	-$19.9M	6.98%	4
2017 Q1	$83.7M	Sell	5,664,219 -295,600	-5%	-$4.79M	11.74%	1
2016 Q4	$96.4M	Buy	5,959,819 +456,637	+8%	+$8.28M	10.92%	1
2016 Q3	$99.8M	Sell	5,503,182 -1,360,666	-20%	-$26.6M	9.47%	1
2016 Q2	$113M	Buy	6,863,848 +40,471	+0.6%	+$655K	12.53%	2
2016 Q1	$113M	Sell	6,823,377 -1,307,933	-16%	-$22.9M	13.12%	1
2015 Q4	$176M	Buy	8,131,310 +1,465,919	+22%	+$28.5M	12.66%	1
2015 Q3	$132M	Buy	6,665,391 +1,849,584	+38%	+$58.4M	10.52%	2
2015 Q2	$167M	Sell	4,815,807 -2,237,697	-32%	-$68.3M	10.99%	2
2015 Q1	$183M	Sell	7,053,504 -1,864,471	-21%	-$34.2M	14.62%	1
2014 Q4	$115M	Buy	8,917,975 +3,829,092	+75%	+$47.9M	10.07%	1
2014 Q3	$62.5M	Buy	5,088,883 +735,669	+17%	+$8.55M	6.56%	2
2014 Q2	$68.9M	Buy	4,353,214 +47,745	+1%	+$681K	6.72%	2
2014 Q1	$65.1M	Buy	4,305,469 +48,000	+1%	+$542K	6.31%	2
2013 Q4	$32.4M	Buy	4,257,469 +2,377,469	+126%	+$12.8M	4.28%	6
2013 Q3	$6.3M	Buy	+1,880,000	New	+$4.96M	1.12%	27